Skip to content

The Clinical Effect of Decortication in Bone Augmentation Surgery for Dental Implants

The Clinical Effect of Decortication in Bone Augmentation Surgery for Dental Implants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125527
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-05-31
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reconstruction of the Alveolar Process After Tooth Loss

Interventions

Control group:No drilling procedure performed, autologous bone graft powder directly implanted into the bone augmentation area. 3D printed personalized titanium mesh used for space maintenance
Trial group 1:Three holes per tooth position uniformly created in the bone augmentation area, autologous bone graft powder implanted into the bone augmentation area. 3D printed personalized titanium m
Trial group 2:Six holes per tooth position uniformly created in the bone augmentation area, autologous bone graft powder implanted into the bone augmentation area. 3D printed personalized titanium mes

Sponsors

School and Hospital of Stomatology, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years, either gender; 2. Severe atrophy of the alveolar process with bone volume insufficient for simultaneous implant placement, requiring bone augmentation surgery; 3. Willing to cooperate with imaging and histological examinations; 4. Stable systemic health status and able to tolerate implant surgery; 5. Good oral hygiene and able to cooperate with postoperative oral care and follow-up.

Exclusion criteria

Exclusion criteria: 1. Recent myocardial infarction (within 1 year); 2. Recent prosthetic valve surgery (within 1 year); 3. Severe renal insufficiency; 4. Uncontrolled endocrine disorders; 5. History of bisphosphonate or denosumab use; 6. Patients who have recently undergone radiotherapy or chemotherapy; 7. Drug or alcohol abuse; 8. Patients requiring regular steroid use; 9. Other conditions: psychiatric disorders, hematologic diseases (e.g., leukemia, hemophilia, coagulation disorders, etc.), cachexia, etc.

Design outcomes

Primary

MeasureTime frame
Percentage of new bone formation;Volume and density of regenerated bone;

Secondary

MeasureTime frame
Postoperative complications;

Countries

China

Contacts

Public ContactYang Ying

School and Hospital of Stomatology, Wenzhou Medical University

dentistyang@wmu.edu.cn+86 577 88061319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026